Latest Health stories from Life.
A judge's recent decision to approve Purdue Pharma's criminal sentence sets the stage for the company's dissolution, highlighted by poignant testimonies from those impacted by the opioid epidemic.
J. Craig Venter, a transformative figure in the field of genetics, passed away at the age of 79. His ambition reshaped the landscape of biotechnology, though he often faced misunderstanding.
Katherine Szarama has been appointed as the acting director of the FDA’s Center for Biologics Evaluation and Research, succeeding Vinay Prasad.
A recent report highlights the ongoing struggles many Americans face in affording health care, particularly among uninsured adults and marginalized communities.
A look into Dr. Nicole Saphier's previous comments on critical health topics such as vaccines, autism, and diet as she steps into the role of Surgeon General nominee.
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly?
Following Senate challenges to her nomination, Trump has nominated Dr. Nicole Saphier as the new surgeon general, criticizing Sen. Bill Cassidy for his role in blocking Casey Means.
A recent study published in Science examines the capabilities of an OpenAI model in diagnostic tasks, prompting discussions among scientists about the future of AI in medicine.
The FDA is seeking to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, citing an adequate supply of GLP-1 drugs from major manufacturers.
A new quintuple agonist shows significant effectiveness in treating obesity in mice, while Alector has decided to halt its Alzheimer's trial.
The recent announcement of a top executive's departure from Elevance coincides with the Justice Department's efforts to gain access to him for a Medicare Advantage fraud investigation.
Hinge has launched a new device aimed at alleviating migraine symptoms, recently receiving FDA clearance. This marks a notable achievement for the company in health technology.
Cigna's decision to leave the ACA individual markets next year contributes to growing uncertainty for patients as membership continues to decline amid subsidy issues.
The leading Democrat in the Senate has presented a new health policy plan aimed at reducing costs for patients across various services.
This editorial explores how the increasing integration of artificial intelligence in health care may affect existing racial and ethnic disparities in health outcomes.
This editorial examines the 'test-negative' methodology used to assess the effectiveness of influenza and COVID-19 vaccines, highlighting its advantages and possible drawbacks.
AstraZeneca is set to expand its research and development operations in the U.K. following a favorable trade agreement with the U.S., as the Supreme Court hears arguments on 'skinny labels' in pharmaceuticals.
This editorial examines the current landscape of abortion coverage in the U.S., focusing on federal and state policies affecting Medicaid and private insurance plans.
A recent issue brief sheds light on the policy decisions states are making as they prepare to implement work requirements for Medicaid, drawing on a survey of state officials.
A new survey sheds light on the current state of Medicaid and CHIP programs as states prepare for upcoming policy changes, focusing on eligibility and enrollment.